Biopsy Principles in Oncology
On this page
Direct answer
Plan the biopsy as though the definitive operation is already on the table: a core-needle (Tru-cut) biopsy taken along the long axis of a limb so the tract can be excised, or an incisional biopsy oriented to the future incision, is oncologically safe; a biopsy done without that plan is the commonest self-inflicted wound in cancer surgery. Suspected melanoma is biopsied by complete excision with a 2–3 mm margin because Breslow thickness — the number that stages the patient — demands a full-thickness specimen. FNAC suits thyroid nodules and breast lumps as a first test but cannot assess architecture, so lymphoma needs an intact node, and sarcoma needs a core.
What you must remember
- FNAC (fine-needle aspiration cytology): cheap, quick, office-based; the first line for thyroid nodules and breast lumps; it reports cytology only — no architecture — so it cannot diagnose follicular lymphoma or follicular thyroid neoplasms reliably.
- Core-needle (Tru-cut) biopsy: the standard for sarcoma, breast (triple assessment) and prostate; provides histology, grade and receptor/immunohistochemistry.
- Sarcoma biopsy rules: longitudinal tract along the limb axis, through the future incision line, away from neurovascular bundles, avoid haematoma contaminating planes — the tract is excised at definitive resection.
- Suspected melanoma: complete excisional biopsy with a 2–3 mm clinical margin for full-thickness Breslow measurement; punch or shave biopsy only for large flat lesions in cosmetically difficult sites — never a shave through a raised pigmented lesion.
- Lymphoma: excisional node biopsy in toto (architecture and flow cytometry/molecular studies) — FNAC may raise suspicion but cannot subtype; the freshest tissue goes for flow cytometry.
- Incisional versus excisional biopsy: small (<3–4 cm), superficial lesions are excised whole with a margin; large, deep or fixed lesions are sampled.
- Needle-tract seeding is rare but real (classically in sarcoma and hepatocellular carcinoma) — the justification for tract excision and for routing percutaneous paths through resectable tissue.
- Bone lesions: Jamshidi trephine biopsy; for suspected osteosarcoma the biopsy tract is likewise excised with the specimen.
- Frozen section has defined roles: margin assessment, sentinel-node touch, confirming viable diagnostic tissue — not definitive grading of a sarcoma.
- Never biopsy a testicular lump by needle — orchidectomy through an inguinal incision is both biopsy and treatment, because of scrotal wall seeding; a classical Indian viva point.
Planning a sarcoma biopsy correctly, then repairing a bad one
A 45-year-old has an 8 cm deep thigh mass. The Tru-cut route is planned jointly: the needle passes through skin that will lie within the future excision flap, parallel to the thigh's long axis, sampling the viable periphery without crossing the femoral vessels. Three cores yield a high-grade myxoid liposarcoma; after neoadjuvant radiotherapy, definitive resection excises the scar and tract en bloc with the tumour — R0.
Contrast the referral after a peripheral hospital has "removed the lump" through a transverse incision: histology shows sarcoma. This unplanned excision is managed by re-imaging for residual disease and wide re-excision of the whole field including scar and seroma cavity, accepting that local control is worse than after a planned primary resection — the biopsy, not the resection, determined the outcome.
Where students slip
The first error is the shave biopsy of a pigmented lesion: it destroys the ability to measure Breslow thickness, staging is lost, and the answer for any suspected melanoma is complete excision with a couple of millimetres. The second is transverse incisions and drains through virgin compartments — each violated centimetre must later be excised, and some biopsies convert limb salvage into amputation. The third is the organ-specific reflex error: offering needle biopsy for a testicular mass (inguinal orchidectomy instead) or trusting FNAC to diagnose lymphoma (excision node biopsy instead). Candidates who articulate why — seeding risk and architecture, respectively — rather than merely what, collect the viva marks.
Frequently asked questions
Why is core-needle biopsy preferred over FNAC for sarcoma?
Diagnosis and grading require architecture and immunohistochemistry, which cores provide and cytology cannot; grade determines prognosis and neoadjuvant decisions.
How should a suspected melanoma be biopsied?
By complete excisional biopsy with a 2–3 mm clinical margin, orientated for the pathologist, so the Breslow thickness can be measured on a full-thickness specimen.
Why does lymphoma need an excised whole node?
Subtyping depends on nodal architecture plus flow cytometry and molecular studies on fresh tissue; FNAC cytology alone cannot distinguish many lymphoma subtypes.
How is the biopsy tract handled at definitive sarcoma resection?
It is excised en bloc with the tumour and scar — the justification for placing the tract along the long axis of the limb through the future incision line.
What is the risk of needle-tract seeding?
Rare implantation of tumour cells along the biopsy path, classically described with sarcoma and hepatocellular carcinoma; tract excision and careful route planning mitigate it.
Why is a testicular tumour never biopsied by needle?
Needling risks seeding tumour into the scrotal wall and changing the disease's lymphatic territory; inguinal orchidectomy with clamping of the cord provides diagnosis and treatment in one step.